Bordetella pertussis, Finland and France

We used pulsed-field gel electrophoresis analysis and genotyping to compare clinical isolates of Bordetella pertussis recovered since the early 1990s in Finland and France, 2 countries with similar histories of long-term mass vaccination with whole-cell pertussis vaccines. Isolates from both countries were similar genetically but varied temporally.

[1]  J. Mertsola,et al.  Strain Variation among Bordetella pertussis Isolates in Finland, Where the Whole-Cell Pertussis Vaccine Has Been Used for 50 Years , 2005, Journal of Clinical Microbiology.

[2]  F. Mooi,et al.  Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. , 2005, Microbes and infection.

[3]  S. Plotkin.  Aims, Scope and Findings of the Global Pertussis Initiative , 2005, The Pediatric infectious disease journal.

[4]  J. Caro,et al.  Potential Strategies to Reduce the Burden of Pertussis , 2005, The Pediatric infectious disease journal.

[5]  Seema Mattoo,et al.  Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies , 2005, Clinical Microbiology Reviews.

[6]  F. Mooi,et al.  Temporal trends in circulating Bordetella pertussis strains in Australia , 2004, Epidemiology and Infection.

[7]  Masahiro Tanaka,et al.  Trends in pertussis among infants in the United States, 1980-1999. , 2003, JAMA.

[8]  G. De Serres,et al.  Strain Variation among Bordetella pertussis Isolates from Québec and Alberta Provinces of Canada from 1985 to 1994 , 2003, Journal of Clinical Microbiology.

[9]  S. Halperin,et al.  Pertussis of adults and infants. , 2002, The Lancet. Infectious diseases.

[10]  S. Thiberge,et al.  Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity. , 2002, Vaccine.

[11]  C. Boursaux-Eude,et al.  Polymorphism of Bordetella pertussisIsolates Circulating for the Last 10 Years in France, Where a Single Effective Whole-Cell Vaccine Has Been Used for More than 30 Years , 2001, Journal of Clinical Microbiology.

[12]  I. V. van Loo,et al.  Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. , 2001, Vaccine.

[13]  R. George,et al.  Genotypic Variation in the Bordetella pertussis Virulence Factors Pertactin and Pertussis Toxin in Historical and Recent Clinical Isolates in the United Kingdom , 2001, Infection and Immunity.

[14]  F. Mooi,et al.  Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. , 1999, Microbiology.

[15]  F. Mooi,et al.  Polymorphism in the Bordetella pertussisVirulence Factors P.69/Pertactin and Pertussis Toxin in The Netherlands: Temporal Trends and Evidence for Vaccine-Driven Evolution , 1998, Infection and Immunity.

[16]  R. Weyant,et al.  Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. , 2002, Emerging infectious diseases.